Abstract: Provided are compositions and materials that have varistor properties and are suitable for use in electrical stress control devices and surge arrestor devices. The compositions and materials include a polymeric material and calcined calcium copper titanate filler material and have a reversible non-linear current-voltage characteristic.

Abstract: Provided are compositions and materials that have varistor properties and are suitable for use in electrical stress control devices and surge arrestor devices. The compositions and materials include a polymeric material and calcined calcium copper titanate filler material and have a reversible non-linear current-voltage characteristic.

Abstract: Versions of the present invention have many advantages, including providing communication devices that can transact on a universal peripheral device with a host device that may have different serial interface connectors, proprietary communication protocols or mechanical shapes. Among the many other advantages include that the peripheral device does not need a power source aside from the power supplied to it by the host device. One embodiment is a communication device comprising a host device comprised of software and an audio connector input; a peripheral device comprised of an analog and digital processor, a card reader and an audio connector output; and an audio connector line connecting said audio connector output and said audio connector input.

Abstract: A system and method for a patch-like, self-contained multi-component substance infusion device which provides one or more substantially hidden patient needles which can be placed in fluid communication with a fluid reservoir assembly that includes a rigid bladder portion used in conjunction with a non-distensible bladder film, such as a metallized film. The device can be attached to a skin surface via an adhesive contact and a pressurization system provides a pressure to the contents of a fluid reservoir assembly. Improvements to dry powdered formulations for reconstitution for preferred use in the device are also disclosed.

Abstract: A system and method for a patch-like, self-contained multi-component substance infusion device which provides one or more substantially hidden patient needles which can be placed in fluid communication with a fluid reservoir assembly that includes a rigid bladder portion used in conjunction with a non-distensible bladder film, such as a metallized film. The device can be attached to a skin surface via an adhesive contact and a pressurization system provides a pressure to the contents of a fluid reservoir assembly. Improvements to dry powdered formulations for reconstitution for preferred use in the device are also disclosed.

Abstract: A system and method for a patch-like, self-contained multi-component substance infusion device which provides one or more substantially hidden patient needles which can be placed in fluid communication with a fluid reservoir assembly that includes a rigid bladder portion used in conjunction with a non-distensible bladder film, such as a metallized film. The device can be attached to a skin surface via an adhesive contact and a pressurization system provides a pressure to the contents of a fluid reservoir assembly. Improvements to dry powdered formulations for reconstitution for preferred use in the device are also disclosed.

Abstract: A system and method for a patch-like, self-contained multi-component substance infusion device which provides one or more substantially hidden patient needles which can be placed in fluid communication with a fluid reservoir assembly that includes a rigid bladder portion used in conjunction with a non-distensible bladder film, such as a metallized film. The device can be attached to a skin surface via an adhesive contact and a pressurization system provides a pressure to the contents of a fluid reservoir assembly. Improvements to dry powdered formulations for reconstitution for preferred use in the device are also disclosed.

Abstract: Provided is a composition comprising a polymeric material, a filler material dispersed in the polymeric material, the filler material comprising inorganic particles and a discontinuous arrangement of conductive material wherein at least a portion of the conductive material is in durable electrical contact with the inorganic particles, and conductive material dispersed in the polymeric material.

Abstract: A sensor assembly has a plurality of sensing elements configured to be positioned within a seat of a vehicle. Each of the sensing elements include an output signal indicating the presence or absence of an occupant. The sensor assembly includes a cable with a plurality of conductors that are in electrical communication with the output signals of the sensing elements. The sensor assembly further provides a non-conductive spacer positioned between the cable and the plurality of sensing elements. A method for providing a sensor assembly having a spacer between sensing elements and conductors attached thereto to reduce unwanted coupling of signals onto the conductors is also disclosed.

Abstract: A sensor assembly has a plurality of sensing elements configured to be positioned within a seat of a vehicle. Each of the sensing elements include an output signal indicating the presence or absence of an occupant. The sensor assembly includes a cable with a plurality of conductors that are in electrical communication with the output signals of the sensing elements. The sensor assembly further provides a non-conductive spacer positioned between the cable and the plurality of sensing elements. A method for providing a sensor assembly having a spacer between sensing elements and conductors attached thereto to reduce unwanted coupling of signals onto the conductors is also disclosed.

Abstract: The present invention relates to a composite microsphere system comprising poly(D,L-lactide-co-glycolide) (PLGA), poly(acryloyl hydroxyethyl starch) (AcHES), and a pharmaceutically effective amount of a biologically active compound. The active compound may be, for example, an insulin, an interferon, a luteinizing hormone-releasing hormone (LHRH) analog, a somatostatin and/or derivatives thereof, a calicitonin, a parathyroid hormone (PTH), a bone morphogenic protein (BMP), an erythropoietin (EPO), an epidermal growth factor (EGF) or a growth hormone. This invention also relates to methods of using the composite microspheres, and methods of preparing same.

Abstract: A system and method for a patch-like, self-contained multi-component substance infusion device which provides one or more substantially hidden patient needles which can be placed in fluid communication with a fluid reservoir assembly that includes a rigid bladder portion used in conjunction with a non-distensible bladder film, such as a metallized film. The device can be attached to a skin surface via an adhesive contact and a pressurization system provides a pressure to the contents of a fluid reservoir assembly. Improvements to dry powdered formulations for reconstitution for preferred use in the device are also disclosed.

Abstract: The present invention provides compositions and delivery methods to enhance treatment for sexual dysfunction or hypofunction through the delivery of phosphodiesterase 5 inhibitors to a mammal. Phosphodiesterase 5 inhibitors are one example of a compound class used for this indication. Examples of compounds in this class include taldalafil and vardenafil and sildenafil. Furthermore, the present invention provides compositions and delivery methods to enhance the sildenafil concentration in solution, suspension and gel formulations and methods of parenteral, intradermal, sublingual, intranasal, and buccal sildenafil delivery.

Abstract: The present invention relates to dermal vaccine formulations, designed for targeted delivery of an immunogenic composition to a dermal compartment of skin including the intradermal and epidermal compartments. The dermal vaccine formulations of the invention comprise an antigenic or immunogenic agent, and at least one molecule, e.g., a chemical agent, which enhances the presentation and/or availability of the antigenic or immunogenic agent to the immune cells of the intradermal compartment or epidermal compartment resulting in an enhanced immune response. The dermal vaccine formulations of the invention have enhanced efficacy as the antigenic or immunogenic agent is delivered to the intradermal compartment or epidermal compartment with enhanced presentation and/or availability to the immune cells that reside therein.